John M. Centanni
General Counsel at COYA THERAPEUTICS, INC.
Profile
John M.
Centanni is Manager of Regulatory Affairs and Quality Assurance and Senior Scientist of Stratatech Corp.
He joined Stratatech in 2001.
He was a Researcher at the NCI- Frederick Cancer Research Center.
Mr. Centanni received an MS degree in Biomedical Sciences.
John M. Centanni active positions
| Companies | Position | Start |
|---|---|---|
| COYA THERAPEUTICS, INC. | General Counsel | 2022-02-28 |
Former positions of John M. Centanni
| Companies | Position | End |
|---|---|---|
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | General Counsel | - |
Stratatech Corp.
 Stratatech Corp. Miscellaneous Commercial ServicesCommercial Services Stratatech Corp. develops and provides genetically enhanced tissues. The firm focuses on skin regeneration therapies for severe burns and other rare diseases, as well as chronic non-healing ulcers. The company was founded by B. Lynn Allen-Hoffmann in 2000 and is headquartered in Madison, WI. | General Counsel | - |
Training of John M. Centanni
| Hood College | Graduate Degree |
| University of Wisconsin Oshkosh | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| COYA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Stratatech Corp.
Stratatech Corp. Miscellaneous Commercial ServicesCommercial Services Stratatech Corp. develops and provides genetically enhanced tissues. The firm focuses on skin regeneration therapies for severe burns and other rare diseases, as well as chronic non-healing ulcers. The company was founded by B. Lynn Allen-Hoffmann in 2000 and is headquartered in Madison, WI. | Commercial Services |
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- John M. Centanni